Leeb front

Seeing Upside 04-15-14

After the worst one-week performance since June 2012, this week U.S. stocks have logged two straight days in the green. Despite swinging into a loss during morning trading today, stocks recovered in the afternoon and finished strongly, as they did yesterday. The tone of the action, however, still leaves something to be desired and continues to suggest—and confirmed by our proprietary stock indicator—a slight negative bias. The small-cap stocks, which typically lead during bull markets, as they have been in recent weeks, again lagged the blue chips. Read more about Seeing Upside 04-15-14

Special Market Update 04-11-14

Yesterday, U.S. stocks experienced one of their worst days of the year. The S&P 500 declined more than 2 percent for the third time this year, and after today’s action, all of the major averages are underwater for the year. Read more about Special Market Update 04-11-14

Wall Street Eyes Weather-Frosted Earnings 04-08-14

It might be difficult to interpret Wall Street’s mood at present. After weak January trading, stocks rallied in February and March as economic data improved. Inclement weather faded, helping boost stocks beyond seasonal lows into ever-higher territory. The S&P 500 Index set another record high in early April. Read more about Wall Street Eyes Weather-Frosted Earnings 04-08-14

A Manufactured Recovery 04-01-14

Things are looking up. The Institute for Supply Management (ISM) today reported that the U.S. manufacturing index in March hit a strong 53.7, up from 53.2 in February, albeit shy of the 54 economists had expected. Any measure above 50 indicates an expansion in economic activity. U.S. manufacturing has grown or at least been flat in all but one month since July 2009 in the midst of 58 consecutive months of overall economic expansion. Read more about A Manufactured Recovery 04-01-14

Hold Steady on the Pharmaceutical Front 03-25-14

The stock market did not react well to Federal Reserve Chair Janet Yellen’s comment last Wednesday suggesting that the central bank could raise interest rates in a little more than a year, sooner than investors had previously expected. However, giving too much weight to one comment over the rest of the Fed’s position could be a huge mistake. After all, the Fed also said that it plans to keep interest rates much lower than normal once inflation rises and unemployment drops to generally accepted levels. Read more about Hold Steady on the Pharmaceutical Front 03-25-14

After Winter, Spring 03-18-2014

Following a rough patch in domestic equity markets to start the year, the switch to Daylight Savings is finally behind us and along with it, Winter. As we enter Spring, the U.S. economy finally seems ready to further advance the progress made in 2013; at least recent data suggests as much. Read more about After Winter, Spring 03-18-2014

All Part of the Cycle 03-11-14

The equity rally turned five years old last week as the S&P 500 continues to close at or near record highs. After reaching a low of 666 on March 6, 2009, the S&P 500 has rocketed up 34% in 2013, 60% since 2011 and an astronomical 205% from its 2009 lows. While these extraordinary returns have helped portfolios recover from 2007 and 2008, the general investor’s psyche lags the market. Read more about All Part of the Cycle 03-11-14